Goldman Sachs Reports That They Have Downgraded China Petroleum (NYSE:SNP) Shares

June 5, 2018 - By Richard Conner

China Petroleum (NYSE:SNP) Receives a Downgrade

The rating of China Petroleum (NYSE:SNP) was lowered today by equity analysts at Goldman Sachs to a Hold rating in an analyst note.

China Petroleum & Chemical Corporation (NYSE:SNP) Ratings Coverage

Among 2 analysts covering China Petroleum and Chemical (NYSE:SNP), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. China Petroleum and Chemical had 2 analyst reports since December 6, 2017 according to SRatingsIntel. The firm has “Neutral” rating by Nomura given on Wednesday, December 6. The stock of China Petroleum & Chemical Corporation (NYSE:SNP) earned “Neutral” rating by Goldman Sachs on Monday, June 4.

The stock decreased 0.58% or $0.56 during the last trading session, reaching $96.62. About 328,487 shares traded or 71.39% up from the average. China Petroleum & Chemical Corporation (NYSE:SNP) has risen 13.93% since June 5, 2017 and is uptrending. It has outperformed by 1.36% the S&P500.

China Petroleum & Chemical Corporation, an energy and chemical company, engages in the gas and oil, and chemical activities and businesses in the People's Republic of China. The company has market cap of $109.53 billion. It operates through five divisions: Exploration and Production, Refining, Marketing and Distribution, Chemicals, and Corporate and Others. It has a 13.24 P/E ratio. The firm explores and develops oil fields; produces natural gas and crude oil; processes and purifies crude oil; and makes and sells petroleum products.

Another recent and important China Petroleum & Chemical Corporation (NYSE:SNP) news was published by Investorplace.com which published an article titled: “20 Oil Stocks for an Unpredictable Second Half” on May 24, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: